Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Guanine synthesis inhibitor for glioblastoma

January 28, 2025 12:43 AM UTC

A small molecule prodrug inhibitor of the guanine synthesis enzyme IMPDH2, which is converted to its active form by NAD salvage enzymes, could help treat glioblastoma by causing nucleotide imbalance, interfering with DNA synthesis required for proliferation, without affecting other dividing cells.

In pooled primary mouse glioblastoma cells from tumors that spontaneously arose in mice deficient in three common glioblastoma tumor suppressors, a screen for compounds that inhibited glioblastoma proliferation with IC50s in the nanomolar range, combined with a screen to rule out antimitotic compounds, identified (N-(pyridin-3-yl)thiophene-2-carboxamide, dubbed gliocidin, which inhibited tumor cell proliferation with an IC50 of 200nM, but had no observable effect on healthy dividing mouse fibroblasts...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article